Apotex Corp. is recalling approximately 2,010 bottles of Aripiprazole Tablets, USP 20 mg, which is a generic version of the medication Abilify. This recall was initiated after a stability test at the 12-month mark showed that the tablets failed to meet dissolution specifications. No incidents or injuries have been reported to date in connection with this recall.
If a tablet fails to dissolve properly, the medication may not be fully absorbed by the body. This can lead to a reduction in the drug's effectiveness, potentially causing a relapse or worsening of psychiatric symptoms in patients relying on the medication.
You have 2 options:
Recall #: D-1285-2022. Quantities distributed in 1,000-count and 30-count bottles.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.